Background—Amiodarone-induced thyrotoxicosis (AIT) is a difficult management problem
about which there are little published data. We examined whether continuing amiodarone or …

Background: Amiodarone is a powerful antiarrhythmic drug; however, its use may be
complicated by thyrotoxicosis. When this occurs, clinicians must balance the continuation of …

Amiodarone causes thyrotoxicosis in 3% of US patients who use it. Two types of amiodarone-
induced thyrotoxicosis are recognized, designated type 1 and type 2, based on whether or …

Amiodarone is used increasingly in a number of cardiac conditions. Amiodarone is heavily
iodinated and can cause thyroid dysfunction. The diagnosis of amiodarone-induced …

Objectives: This study sought to determine the clinical course and predictors of long-term
outcome in patients with documented amiodarone-induced thyrotoxicosis (AIT). Background …

Context: Amiodarone-induced thyrotoxicosis (AIT) type 2 is self-limiting in nature, but most
physicians are reluctant to continue amiodarone. When prednisone fails to restore …

Background. Amiodarone-induced thyrotoxicosis (AIT) is a rare disorder that is frequently
refractory to conventional pharmacologic therapy. Methods. An analysis of seven patients …

Background Amiodarone-induced thyrotoxicosis (AIT) develops in 3% of amiodarone-
treated patients in North America. AIT is classified as type 1 or type 2. Type 1 AIT occurs in …

Amiodarone, a benzofuranic iodine-rich antiarrhythmic drug, causes thyroid dysfunction in
15–20% of cases. Although amiodarone-induced hypothyroidism poses no particular …

Amiodarone (AM), a potent class III anti-arrhythmic drug, is an iodine-rich compound with a
structural resemblance to thyroid hormones triiodothyronine (T3) and thyroxine (T4). At the …